STAAR Surgical Company
STAANASDAQHealthcare● Active
$30.25
+$0.26(+0.87%)
Market Cap$1.5B
P/E Ratio—
52W High$35.87
52W Low$15.59
STAAR Surgical Company (STAA) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
STAA · earnings · updated Jun 8, 2026
Latest Earnings
Q2 FY2026Report Date: May 13, 2026EPS Actual
$0.38
Est. $0.05 · +600.9%
Revenue
$0.09B
Est. $0.08B · +18.8%
Fiscal Period
Q2 FY2026
FY ends December
Report Date
May 13, 2026
After Market Close
▲ Beat EPS▲ Beat Revenue✓ 1-Quarter EPS Beat Streak
STAA reports quarterly as a NASDAQ-listed Medical - Instruments & Supplies company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
85
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Rev. $0.58B
Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
Rev. Est.$0.58B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Aug 12, 2026 | $0.21 | — | — | — | $0.09B | — |
| ▲ Q2 FY2026 | May 13, 2026 | $0.05 | $0.38 | +600.9% | $0.09B | $0.08B | +18.8% |
| ▼ Q1 FY2026 | Mar 3, 2026 | $0.18 | -$0.20 | -211.1% | $0.06B | $0.07B | -22.9% |
| ▲ Q4 FY2025 | Nov 5, 2025 | $0.18 | $0.46 | +155.6% | $0.09B | $0.08B | +25.4% |
| ▲ Q3 FY2025 | Aug 6, 2025 | -$0.56 | -$0.07 | +87.5% | $0.04B | $0.09B | -50.3% |
| ▲ Q2 FY2025 | May 7, 2025 | -$0.59 | -$0.52 | +11.9% | $0.04B | $0.04B | +5.7% |
| ▼ Q1 FY2025 | Feb 11, 2025 | $0.02 | -$0.50 | -2600.0% | $0.05B | $0.08B | -36.8% |
| ▲ Q4 FY2024 | Oct 30, 2024 | $0.19 | $0.37 | +94.7% | $0.09B | $0.08B | +13.8% |
Q3 FY2026
Aug 12, 2026
EPS Actual
—
EPS Est.
$0.21
EPS Surpr.
—
Revenue
—
Q2 FY2026
May 13, 2026Beat
EPS Actual
$0.38
EPS Est.
$0.05
EPS Surpr.
+600.9%
Revenue
$0.09B
Q1 FY2026
Mar 3, 2026Miss
EPS Actual
-$0.20
EPS Est.
$0.18
EPS Surpr.
-211.1%
Revenue
$0.06B
Q4 FY2025
Nov 5, 2025Beat
EPS Actual
$0.46
EPS Est.
$0.18
EPS Surpr.
+155.6%
Revenue
$0.09B
Q3 FY2025
Aug 6, 2025Beat
EPS Actual
-$0.07
EPS Est.
-$0.56
EPS Surpr.
+87.5%
Revenue
$0.04B
Q2 FY2025
May 7, 2025Beat
EPS Actual
-$0.52
EPS Est.
-$0.59
EPS Surpr.
+11.9%
Revenue
$0.04B
Q1 FY2025
Feb 11, 2025Miss
EPS Actual
-$0.50
EPS Est.
$0.02
EPS Surpr.
-2600.0%
Revenue
$0.05B
Q4 FY2024
Oct 30, 2024Beat
EPS Actual
$0.37
EPS Est.
$0.19
EPS Surpr.
+94.7%
Revenue
$0.09B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q1 FY2029 | $0.06 | $0.07 | $0.08 | 2 |
| Q4 FY2028 | $0.20 | $0.22 | $0.25 | 3 |
| Q3 FY2028 | $0.22 | $0.25 | $0.28 | 3 |
| Q2 FY2028 | $0.30 | $0.33 | $0.38 | 3 |
| Q1 FY2028 | $0.15 | $0.16 | $0.19 | 3 |
| Q4 FY2027 | $0.21 | $0.23 | $0.26 | 2 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q1 FY2029 | $0.1B | $0.1B | $0.1B | 5 |
| Q4 FY2028 | $0.1B | $0.1B | $0.1B | 2 |
| Q3 FY2028 | $0.1B | $0.1B | $0.1B | 2 |
| Q2 FY2028 | $0.1B | $0.1B | $0.1B | 2 |
| Q1 FY2028 | $0.1B | $0.1B | $0.1B | 2 |
| Q4 FY2027 | $0.1B | $0.1B | $0.1B | 3 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▲ Q2 FY2026 | May 13, 2026 | +600.9% | $28.18 | $29.40 | +4.33% |
| ▼ Q1 FY2026 | Mar 3, 2026 | -211.1% | $19.05 | $18.92 | -0.68% |
| ▲ Q4 FY2025 | Nov 5, 2025 | +155.6% | $25.28 | $25.25 | -0.12% |
| ▲ Q3 FY2025 | Aug 6, 2025 | +87.5% | $27.02 | $26.90 | -0.44% |
| ▲ Q2 FY2025 | May 7, 2025 | +11.9% | $18.64 | $19.44 | +4.29% |
| ▼ Q1 FY2025 | Feb 11, 2025 | -2600.0% | $22.61 | $21.88 | -3.23% |
| ▲ Q4 FY2024 | Oct 30, 2024 | +94.7% | $30.29 | $29.49 | -2.64% |
| ▲ Q3 FY2024 | Aug 7, 2024 | +32.0% | $37.89 | $36.35 | -4.06% |
Q2 FY2026+4.33%
Report Date
May 13, 2026
EPS Beat/Miss
+600.9%
Price Before
$28.18
Price After
$29.40
Q1 FY2026-0.68%
Report Date
Mar 3, 2026
EPS Beat/Miss
-211.1%
Price Before
$19.05
Price After
$18.92
Q4 FY2025-0.12%
Report Date
Nov 5, 2025
EPS Beat/Miss
+155.6%
Price Before
$25.28
Price After
$25.25
Q3 FY2025-0.44%
Report Date
Aug 6, 2025
EPS Beat/Miss
+87.5%
Price Before
$27.02
Price After
$26.90
Q2 FY2025+4.29%
Report Date
May 7, 2025
EPS Beat/Miss
+11.9%
Price Before
$18.64
Price After
$19.44
Q1 FY2025-3.23%
Report Date
Feb 11, 2025
EPS Beat/Miss
-2600.0%
Price Before
$22.61
Price After
$21.88
Q4 FY2024-2.64%
Report Date
Oct 30, 2024
EPS Beat/Miss
+94.7%
Price Before
$30.29
Price After
$29.49
Q3 FY2024-4.06%
Report Date
Aug 7, 2024
EPS Beat/Miss
+32.0%
Price Before
$37.89
Price After
$36.35
Avg Beat Reaction+0.23%
Avg Miss Reaction-1.96%
Beat Rate6 / 8 quarters
Largest Move+4.33% (Q2 FY2026)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: STAA ends December
STAAR Surgical Company (STAA) most recently reported earnings on May 13, 2026 for Q2 FY2026, posting EPS of $0.38 — beating the analyst consensus of $0.05 by +600.9%. The next STAA earnings date is expected around September 1, 2026.
Each quarter, investors track STAA earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. STAA revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
STAA's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
STAA earnings · 5 questionsSTAAR Surgical Company's next earnings report is expected around September 1, 2026. STAA typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; STAA historically reports after market close (AMC).
STAA earnings datewhen is STAA earningsSTAA next earnings datewhen does STAA report earningsSTAA earnings calendar
▸ Source: FMP · STAAR Surgical Company SEC filings · US GAAP · STAAR Surgical Company SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026